MERREM I — Class II drug recall D-840-2013
Terminated recall by AstraZeneca Pharmaceuticals LP, reported 2013-08-14, distributed in PR. Presence of Precipitate; potential for incomplete constitution upon addition of diluent.
| Recall number | D-840-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AstraZeneca Pharmaceuticals LP, Wilmington, DE, United States |
| Recall initiated | 2013-06-21 |
| Classified | 2013-08-05 |
| Reported by FDA | 2013-08-14 |
| Terminated | 2015-01-29 |
| Distributed | PR |
| Quantity | 81,900 vials |
| Lot numbers | JX109, JY042 |
| Expiration dates | 2015-02 |
Product
MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30
Reason for recall
Presence of Precipitate; potential for incomplete constitution upon addition of diluent.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-840-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.